James M. Bennett

4.4k citations

48 papers · 2.0k indexed · h-index 24

Co-authors: Neil R. Stokes David J. Haydon Lloyd G. Czaplewski Ian Collins Jonathan M. Elkins Stefan Knapp Anil Srivastava Susanne Müller
Topics: Protein Degradation and Inhibitors (8 papers)Cancer therapeutics and mechanisms (6 papers)Multiple Myeloma Research and Treatments (5 papers)
Cited by: Molecular Medicine Hematology Molecular Biology
Journals: Science Journal of Biological Chemistry Angewandte Chemie International Edition
Partner nations: United Kingdom United States Brazil

In The Last Decade

James M. Bennett

48 papers receiving 1.9k citations

Peers

Countries citing papers authored by James M. Bennett

Since Specialization

Citations

This map shows the geographic impact of James M. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Bennett more than expected).

Fields of papers citing papers by James M. Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Bennett. The network helps show where James M. Bennett may publish in the future.

Co-authorship network of co-authors of James M. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Bennett. A scholar is included among the top collaborators of James M. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Bennett. James M. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Binding‐Site Purification of Actives (B‐SPA) Enables Efficient Large‐Scale Progression of Fragment Hits by Combining Multi‐Step Array Synthesis With HT Crystallography 2025 ·Angewandte Chemie International Edition ·(unknown),(unknown),(unknown),Warren Thompson,L. Koekemoer,James M. Bennett,A.R. Bradley,C.A. Anderson,Conor Wild,W.J. Bradshaw,Edward A. Fitzgerald,T. Krojer,O. Fedorov,Philip C. Biggin,John Spencer,F. von Delft	2
2	Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases 2024 ·European Journal of Medicinal Chemistry ·(unknown),F.J. Sorrell,James M. Bennett,Oleg Fedorov,(unknown),Paulo H. Godoi,(unknown),Sean W. Robinson,Iva Navrátilová,Jonathan M. Elkins,Simon E. Ward	4
3	Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),James M. Bennett,Thomas Christott,Matthew Dowling,Gillian Farnie,Oleg Fedorov,(unknown),C. Gileadi,Charline Giroud,K. Huber,Magdalena Korczynska,Chris Limberakis,Arjun Narayanan,Dafydd R. Owen,L. Diaz Saez,Ingrid A. Stock,Allyn T. Londregan	4
4	Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors 2023 ·Pathogens ·M. Schuller,Tryfon Zarganes‐Tzitzikas,James M. Bennett,Stéphane De Cesco,D. Fearon,F. von Delft,Oleg Fedorov,Paul E. Brennan,Ivan Ahel	11
5	Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1 2019 ·ACS Medicinal Chemistry Letters ·Xiaomin Ni,David Heidenreich,Thomas Christott,James M. Bennett,Moses Moustakim,Paul E. Brennan,Oleg Fedorov,Stefan Knapp,A. Chaikuad	19
6	Oxalyl Boronates Enable Modular Synthesis of Bioactive Imidazoles 2017 ·Angewandte Chemie ·(unknown),Aleksandra Holownia,James M. Bennett,Jonathan M. Elkins,Jeffrey D. St. Denis,Shinya Adachi,Andrei K. Yudin	28
7	Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk 2016 ·Nature Chemical Biology ·Sara Sdelci,Charles-Hugues Lardeau,C. Tallant,Freya Klepsch,(unknown),James M. Bennett,Philipp Rathert,Michael Schuster,Thomas Penz,O. Fedorov,Giulio Superti‐Furga,Christoph Bock,Johannes Zuber,K. Huber,Stefan Knapp,Susanne Müller,Stefan Kubicek	33
8	LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor 2015 ·Angewandte Chemie ·Peter G. K. Clark,Lucas Campos Curcino Vieira,C. Tallant,O. Fedorov,Dean C. Singleton,Catherine Rogers,Octovia Monteiro,James M. Bennett,Roberta Baronio,Susanne Müller,Danette L. Daniels,Jacqui Méndez,Stefan Knapp,Paul E. Brennan,Darren J. Dixon	111
9	LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor 2015 ·Angewandte Chemie International Edition ·Peter G. K. Clark,Lucas Campos Curcino Vieira,C. Tallant,O. Fedorov,Dean C. Singleton,Catherine Rogers,Octovia Monteiro,James M. Bennett,Roberta Baronio,Susanne Müller,Danette L. Daniels,Jacqui Méndez,Stefan Knapp,Paul E. Brennan,Darren J. Dixon	134
10	Antimicrobial susceptibilities and random amplified polymorphic DNA-PCR fingerprint characterization of Lactococcus lactis ssp. lactis and Lactococcus garvieae isolated from bovine intramammary infections 2015 ·Journal of Dairy Science ·Carme Plumed‐Ferrer,A. Barberio,(unknown),Brenda G. Werner,Patrick L. McDonough,James M. Bennett,G. Gioia,N. Rota,F.L. Welcome,D.V. Nydam,P. Moroni	21
11	Short communication: Genotypic and phenotypic identification of environmental streptococci and association of Lactococcus lactis ssp. lactis with intramammary infections among different dairy farms 2014 ·Journal of Dairy Science ·Brenda G. Werner,P. Moroni,G. Gioia,(unknown),(unknown),(unknown),(unknown),James M. Bennett,D.V. Nydam,F.L. Welcome,Y.H. Schukken	33
12	An Improved Small-Molecule Inhibitor of FtsZ with Superior In Vitro Potency, Drug-Like Properties, and In Vivo Efficacy 2012 ·Antimicrobial Agents and Chemotherapy ·Neil R. Stokes,Nicola Baker,James M. Bennett,(unknown),Ian Collins,Lloyd G. Czaplewski,Alastair Logan,(unknown),(unknown),(unknown),Jeffrey P. Mitchell,(unknown),Anju Yadav,Anil Srivastava,David J. Haydon	76
13	Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties 2010 ·Journal of Medicinal Chemistry ·David J. Haydon,James M. Bennett,David R. Brown,Ian Collins,(unknown),(unknown),(unknown),Neil R. Stokes,(unknown),(unknown),(unknown),Anil Srivastava,(unknown),Robyn N. Hall,(unknown),Caterina Noula,(unknown),Lloyd G. Czaplewski	98
14	An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity 2008 ·Science ·David J. Haydon,Neil R. Stokes,(unknown),(unknown),James M. Bennett,David R. Brown,Patrick J. Baker,V.V. Barynin,David W. Rice,Sveta Sedelnikova,Jonathan R. Heal,J. M. Sheridan,Sachin T. Aiwale,(unknown),Anil Srivastava,(unknown),Ian Collins,Jeff Errington,Lloyd G. Czaplewski	379
15	Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney,(unknown),Richard T. Buck,(unknown),David J. Phillips,D. I. C. SCOPES,(unknown),Martin Pagé,James M. Bennett,(unknown),Edward A. McKenzie,(unknown),Robert Felix,Colin Stubberfield,Paul R. Turner	59
16	2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney,(unknown),Richard T. Buck,(unknown),David W. Porter,D. I. C. SCOPES,(unknown),Martin Pagé,James M. Bennett,(unknown),Edward A. McKenzie,Colin Stubberfield,Paul R. Turner	42
17	Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening 2003 ·Bioorganic & Medicinal Chemistry Letters ·Stephen D. Pickett,Bradley Sherborne,Trevor Wilkinson,James M. Bennett,Neera Borkakoti,Michael J. Broadhurst,David N. Hurst,(unknown),(unknown),Philip S. Jones	25
18	Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells 2003 ·Biochemical Journal ·Edward A. McKenzie,(unknown),(unknown),James M. Bennett,(unknown),Robert Felix,Paul Turner,Alasdair C. Stamps,David J. McMillan,(unknown),(unknown),(unknown),Daniel Snell,Darren J. Schofield,(unknown),Reid Townsend,J T Gallagher,Martin Pagé,Raj Parekh,Colin Stubberfield	102
19	Characterisation of theAspergillus nidulans frA1 mutant: hexose phosphorylation and apparent lack of involvement of hexokinase in glucose repression 1996 ·FEMS Microbiology Letters ·George J. G. Ruijter,Henk Panneman,(unknown),James M. Bennett,Jaap Visser	26
20	The performance of an integer programming algorithm with text examples 1968 ·Australian Computer Journal ·James M. Bennett,Philip C. Cooley,(unknown)	1

About James M. Bennett

James M. Bennett is a scholar working on Hematology, Molecular Medicine and Molecular Biology, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Cancer therapeutics and mechanisms (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Molecular Medicine (206 citations), Hematology (200 citations) and Molecular Biology (1.2k citations). James M. Bennett has collaborated with scholars based in United Kingdom, United States and Brazil. Frequent co-authors include Neil R. Stokes, David J. Haydon, Lloyd G. Czaplewski, Ian Collins, Jonathan M. Elkins, Stefan Knapp, Anil Srivastava, Susanne Müller, Jeff Errington and Octovia Monteiro. Their work appears in journals such as Science, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact